[Agranulocytosis secondary to a treatment with tisopurine].
D000380:Agranulocytosis / Q000139:chemically induced*; D000493:Allopurinol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy; D006074:Gout Suppressants / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged
D006074:Gout Suppressants; D000493:Allopurinol; C005832:tisopurine
Agranulocytose secondaire à un traitement par la tisopurine.